These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26141809)

  • 1. Common goal areas in the treatment of upper limb spasticity: a multicentre analysis.
    Ashford S; Fheodoroff K; Jacinto J; Turner-Stokes L
    Clin Rehabil; 2016 Jun; 30(6):617-22. PubMed ID: 26141809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Categorisation of goals set using Goal Attainment Scaling for treatment of leg spasticity: a multicentre analysis.
    Ashford S; Williams H; Nair A; Orridge S; Turner-Stokes L
    Disabil Rehabil; 2019 Aug; 41(16):1925-1930. PubMed ID: 29558228
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessing the effectiveness of upper-limb spasticity management using a structured approach to goal-setting and outcome measurement: First cycle results from the ULIS-III Study.
    Turner-Stokes L; Jacinto J; Fheodoroff K; Brashear A; Maisonobe P; Lysandropoulos A; Ashford S;
    J Rehabil Med; 2021 Jan; 53(1):jrm00133. PubMed ID: 33206198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of Botulinum Toxin Treatment for Upper Limb Spasticity Poststroke Over Different ICF Domains: A Systematic Review and Meta-Analysis.
    Andringa A; van de Port I; van Wegen E; Ket J; Meskers C; Kwakkel G
    Arch Phys Med Rehabil; 2019 Sep; 100(9):1703-1725. PubMed ID: 30796921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review of upper-limb function measurement methods in botulinum toxin intervention for focal spasticity.
    Ashford S; Turner-Stokes L
    Physiother Res Int; 2013 Sep; 18(3):178-89. PubMed ID: 23630050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and characteristics of goal attainment following BoNT-A injection for management of spasticity.
    Mullins D; Winter A; Fini N; Dixon C; Aldous S; Palit M; Holland AE
    Disabil Rehabil; 2016 Sep; 38(19):1927-33. PubMed ID: 26714558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Goal Attainment Scaling in Individuals with Upper Limb Spasticity Post Stroke.
    Eftekhar P; Mochizuki G; Dutta T; Richardson D; Brooks D
    Occup Ther Int; 2016 Dec; 23(4):379-389. PubMed ID: 27696580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity.
    Demetrios M; Khan F; Turner-Stokes L; Brand C; McSweeney S
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009689. PubMed ID: 23740539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III).
    Turner-Stokes L; Ashford S; Jacinto J; Maisonobe P; Balcaitiene J; Fheodoroff K
    BMJ Open; 2016 Jun; 6(6):e011157. PubMed ID: 27315835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study.
    Turner-Stokes L; Jacinto J; Fheodoroff K; Brashear A; Maisonobe P; Lysandropoulos A; Ashford S;
    J Rehabil Med; 2021 Feb; 53(2):jrm00157. PubMed ID: 33616192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More than a black box of rehabilitation: Characterizing therapy programmes following botulinum toxin injections for spasticity in adults with stroke.
    Demetrios M; Brand C; Louie J; Khan F
    J Rehabil Med; 2016 Apr; 48(5):426-34. PubMed ID: 27097568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing goal attainment in patients with post-stroke upper limb spasticity following treatment with botulinum toxin A in real-life clinical practice: sub-analyses from the Upper Limb International Spasticity (ULIS)-II Study.
    Fheodoroff K; Ashford S; Jacinto J; Maisonobe P; Balcaitiene J; Turner-Stokes L
    Toxins (Basel); 2015 Apr; 7(4):1192-205. PubMed ID: 25856546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation].
    Khat'kova SE; Baikova A; Maisonobe P; Khasanova DR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11):39-48. PubMed ID: 34932284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of a 15-years' experience in including shoulder muscles, when treating upper-limb spasticity post-stroke with botulinum toxin type A.
    Carvalho MP; Pinto D; Gorayeb M; Jacinto J
    Top Stroke Rehabil; 2018 Apr; 25(3):194-202. PubMed ID: 29322885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial.
    Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Davies L; McCrory P; Hughes A
    J Rehabil Med; 2010 Jan; 42(1):81-9. PubMed ID: 20111849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.
    Marque P; Denis A; Gasq D; Chaleat-Valayer E; Yelnik A; Colin C; ; Pérennou D
    Ann Phys Rehabil Med; 2019 Jul; 62(4):207-213. PubMed ID: 31229700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?
    Nott MT; Barden HL; Baguley IJ
    J Rehabil Med; 2014 Oct; 46(9):864-8. PubMed ID: 25074437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity.
    Baguley IJ; Nott MT; Turner-Stokes L; De Graaff S; Katrak P; McCrory P; de Abadal M; Hughes A
    J Rehabil Med; 2011 Nov; 43(11):1032-7. PubMed ID: 22031350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic review.
    Olvey EL; Armstrong EP; Grizzle AJ
    Clin Ther; 2010 Dec; 32(14):2282-303. PubMed ID: 21353101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.